Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more) Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more) Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vyant Bio Inc VYNT

Healthcare Biotechnology
Vyant Bio, Inc. has no continuing operating activities other than the winddown and closure of its business. The Company is seeking to obtain its shareholders’ approval for the voluntary liquidation and dissolution of the Company, pursuant to a plan of liquidation and dissolution.


PINL:VYNT - Post by User

Vyant Bio Inc
<< Previous
 Bullboard Posts
User Avatar Image
(558)
•••
Post by FacBineon Aug 16, 2019 11:01am
193 Views
Post# 30036457

StageZero Life Sciences - Aristotle

StageZero Life Sciences - Aristotle
Aristotle: 10 Cancers - 1 Sample of Blood - Unlimited Possibilities. Aristotle is our next generation test for simultaneously screening for ten cancers from a single sample of blood. Preliminary data shows we can fully discriminate and detect each cancer with high sensitivity and specificity. More at: https://www.stagezerolifesciences.com/#/
<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities